Literature DB >> 21478842

Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells.

Seth M Taapken, Benjamin S Nisler, Michael A Newton, Tori L Sampsell-Barron, Kimberly A Leonhard, Erik M McIntire, Karen D Montgomery.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21478842     DOI: 10.1038/nbt.1835

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  16 in total

1.  Long-term culture of human embryonic stem cells in feeder-free conditions.

Authors:  Elen S Rosler; Gregory J Fisk; Ximena Ares; John Irving; Takumi Miura; Mahendra S Rao; Melissa K Carpenter
Journal:  Dev Dyn       Date:  2004-02       Impact factor: 3.780

2.  High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity.

Authors:  Elisa Närvä; Reija Autio; Nelly Rahkonen; Lingjia Kong; Neil Harrison; Danny Kitsberg; Lodovica Borghese; Joseph Itskovitz-Eldor; Omid Rasool; Petr Dvorak; Outi Hovatta; Timo Otonkoski; Timo Tuuri; Wei Cui; Oliver Brüstle; Duncan Baker; Edna Maltby; Harry D Moore; Nissim Benvenisty; Peter W Andrews; Olli Yli-Harja; Riitta Lahesmaa
Journal:  Nat Biotechnol       Date:  2010-03-28       Impact factor: 54.908

3.  Tetrasomy 12p (Pallister-Killian syndrome).

Authors:  A Schinzel
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

4.  Genomic alterations in cultured human embryonic stem cells.

Authors:  Anirban Maitra; Dan E Arking; Narayan Shivapurkar; Morna Ikeda; Victor Stastny; Keyaunoosh Kassauei; Guoping Sui; David J Cutler; Ying Liu; Sandii N Brimble; Karin Noaksson; Johan Hyllner; Thomas C Schulz; Xianmin Zeng; William J Freed; Jeremy Crook; Suman Abraham; Alan Colman; Peter Sartipy; Sei-Ichi Matsui; Melissa Carpenter; Adi F Gazdar; Mahendra Rao; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

5.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells.

Authors:  Madhvi B Upender; Jens K Habermann; Lisa M McShane; Edward L Korn; J Carl Barrett; Michael J Difilippantonio; Thomas Ried
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

8.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

Review 9.  Aneuploidy: instigator and inhibitor of tumorigenesis.

Authors:  Beth A A Weaver; Don W Cleveland
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

Review 10.  Defining 'chromosomal instability'.

Authors:  Jochen B Geigl; Anna C Obenauf; Thomas Schwarzbraun; Michael R Speicher
Journal:  Trends Genet       Date:  2008-01-14       Impact factor: 11.639

View more
  136 in total

1.  Non-viral iPSCs: a safe way for therapy?

Authors:  Weiqi Zhang; Di Guan; Jing Qu; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-04       Impact factor: 14.870

Review 2.  Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

Authors:  Kun-Yong Kim; Yong Wook Jung; Gareth J Sullivan; Leeyup Chung; In-Hyun Park
Journal:  Trends Mol Med       Date:  2012-07-06       Impact factor: 11.951

Review 3.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 4.  The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.

Authors:  Zachary S Scheiner; Sohel Talib; Ellen G Feigal
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 5.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 6.  Developing defined culture systems for human pluripotent stem cells.

Authors:  Bahram Valamehr; Hideaki Tsutsui; Chih-Ming Ho; Hong Wu
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

Review 7.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

Review 8.  Strategies for Oral Mucosal Repair by Engineering 3D Tissues with Pluripotent Stem Cells.

Authors:  Kyle J Hewitt; Yulia Shamis; Behzad Gerami-Naini; Jonathan A Garlick
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

Review 9.  Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics.

Authors:  Nicole A J Krentz; Anna L Gloyn
Journal:  Nat Rev Endocrinol       Date:  2020-02-25       Impact factor: 43.330

10.  Passage number is a major contributor to genomic structural variations in mouse iPSCs.

Authors:  Pengfei Liu; Anna Kaplan; Bo Yuan; Jacob H Hanna; James R Lupski; Orly Reiner
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.